Rick J. Bold, M.D., M.B.A.

Contact Us for the Latest Status

• Response Prediction To Chemotherapy Using A Functional Precision Assay In Patients Undergoing Surgical Resection Of Pancreatic Ductal Adenocarcinoma (PDAC) Scottsdale/Phoenix, AZ

  The purpose of this study is to assess the logistical feasibility of performing phenotypic-driven functional precision medicine chemosensitivity report on surgically-resected PDAC specimens shipped to KYAN Technologies’s facilities at Mayo Lab Services (Rochester, MN).